{"id":44789,"date":"2022-06-07T14:01:23","date_gmt":"2022-06-07T12:01:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/"},"modified":"2022-06-07T14:01:23","modified_gmt":"2022-06-07T12:01:23","slug":"thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/","title":{"rendered":"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Industry Veteran Will Lead Sourcing Strategy <\/i><i>for the Firm\u2019s Healthcare Group<\/i>\n<\/p>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthl.com%2F&amp;esheet=52741788&amp;newsitemid=20220607005566&amp;lan=en-US&amp;anchor=Thomas+H.+Lee+Partners%2C+L.P.&amp;index=1&amp;md5=e57bcc81d52a480dd2c948913292bb28\" rel=\"nofollow noopener\" shape=\"rect\">Thomas H. Lee Partners, L.P. <\/a>(\u201cTHL\u201d), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firm\u2019s healthcare investment group. Hendler, who brings over 20 years of experience as an M&amp;A advisor to premier middle-market companies, will lead the firm\u2019s continued work in identifying growth opportunities across the healthcare market.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/4\/THL_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg\"><\/a><\/p>\n<p>\n\u201c<!-- no quote -->THL continues to be a very active investor in the healthcare sector, as we partner with growth companies delivering high quality healthcare services and technology in important subsectors,\u201d said Joshua Nelson, Managing Director and head of the firm\u2019s Healthcare group. \u201c<!-- no quote -->Sam\u2019s industry knowledge and strategic acumen will help THL identify the right places for investment and partnership, and allow us to continue to sharpen our focus on Identified Sector Opportunities (ISOs).\u201d\n<\/p>\n<p>\nIn his new role, Hendler will join other senior leaders of the Healthcare group in developing new Identified Sector Opportunities (ISOs) for future investment and building and maintaining relationships with management teams, investors, and advisors across the healthcare market. He will also lead the group\u2019s sourcing efforts for both new investments and current portfolio companies. The firm currently invests in five healthcare sectors: Healthcare IT, Pharmaceutical Services, Home-based Care, Consumer Healthcare, and Medtech Services.\n<\/p>\n<p>\n\u201c<!-- no quote -->THL has far-reaching relationships across the healthcare industry and deep knowledge of the market,\u201d said Hendler. \u201c<!-- no quote -->The firm\u2019s approach to developing and focusing rigorously on identified sector opportunities has enabled it to work with companies for which it is uniquely positioned to add value. I am excited to join this outstanding team.\u201d\n<\/p>\n<p>\nPrior to joining Thomas H. Lee Partners, Hendler served as a managing director at Harris Williams, where he established and managed the firm\u2019s global healthcare IT practice. Earlier in his career, he worked as an associate with Quellos Private Capital Markets, L.P., and as a Mergers and Acquisitions Analyst with Broadview International, LLC.\n<\/p>\n<p>\n<b>About THL<\/b>\n<\/p>\n<p>\nThomas H. Lee Partners, L.P. (\u201cTHL\u201d) is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology &amp; Services, and Technology &amp; Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity (\u201cISO\u201d) process with dedicated internal operating resources from its Strategic Resource Group (\u201cSRG\u201d) to transform and build great companies of lasting value in partnership with management. The Firm\u2019s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media<\/b><br \/>Elena Connolly<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#69;&#x6c;e&#110;&#x61;&#46;&#99;&#x6f;&#x6e;&#110;&#x6f;&#x6c;l&#121;&#x40;e&#100;&#x65;l&#109;&#x61;&#x6e;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#69;&#108;&#x65;n&#97;&#x2e;&#x63;o&#110;&#x6e;&#x6f;l&#108;&#x79;&#x40;e&#100;&#x65;&#x6c;m&#97;&#x6e;&#x2e;c&#111;&#x6d;<\/a><br \/>+1 (914) 387-2730\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Industry Veteran Will Lead Sourcing Strategy for the Firm\u2019s Healthcare Group BOSTON&#8211;(BUSINESS WIRE)&#8211;Thomas H. Lee Partners, L.P. (\u201cTHL\u201d), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firm\u2019s healthcare investment group. Hendler, who brings over 20 years &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44789","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Industry Veteran Will Lead Sourcing Strategy for the Firm\u2019s Healthcare Group BOSTON&#8211;(BUSINESS WIRE)&#8211;Thomas H. Lee Partners, L.P. (\u201cTHL\u201d), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firm\u2019s healthcare investment group. Hendler, who brings over 20 years ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T12:01:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare\",\"datePublished\":\"2022-06-07T12:01:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/\"},\"wordCount\":489,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005566\\\/en\\\/1478366\\\/21\\\/THL_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/\",\"name\":\"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005566\\\/en\\\/1478366\\\/21\\\/THL_Logo.jpg\",\"datePublished\":\"2022-06-07T12:01:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005566\\\/en\\\/1478366\\\/21\\\/THL_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005566\\\/en\\\/1478366\\\/21\\\/THL_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/","og_locale":"en_US","og_type":"article","og_title":"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare - Pharma Trend","og_description":"Industry Veteran Will Lead Sourcing Strategy for the Firm\u2019s Healthcare Group BOSTON&#8211;(BUSINESS WIRE)&#8211;Thomas H. Lee Partners, L.P. (\u201cTHL\u201d), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firm\u2019s healthcare investment group. Hendler, who brings over 20 years ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-07T12:01:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare","datePublished":"2022-06-07T12:01:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/"},"wordCount":489,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/","url":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/","name":"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg","datePublished":"2022-06-07T12:01:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220607005566\/en\/1478366\/21\/THL_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/thomas-h-lee-partners-appoints-sam-hendler-as-head-of-business-development-healthcare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44789"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44789\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}